Mutations in the isocitrate dehydrogenase (IDH1/2) are highly frequent genetic abnormalities in human cancerous diseases such as glioma, leukemia, chondrosarcoma, and cholangiocarcinoma1–3. Here, IDH1 is linked to central nervous system cancer.